Comparison of Two Different Anesthesia Methods in IVF Procedure
Launched by ACIBADEM UNIVERSITY · Nov 19, 2022
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
130 patients over the age of 18, ASA I-II, who underwent oocyte retrieval for IVF treatment were included in the study. The patients divided into two groups. In induction, 2mg/kg fentanyl, 40mg lidocaine and 2mg/kg propofol administered to all patients. Patients in group 1; propofol added in bolus doses of 0.5mg/kg. Doses determined according to the clinical condition of the patient. Patients in group 2; propofol administered as 10mg/kg/hour infusion. The infusion dose adjusted so that the Bispectral index (BIS) is in the range of 40-60.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years
- • ASA I-II
- • Patients who underwent oocyte retrieval for IVF treatment
- Exclusion Criteria:
- • 1. The patient does not want to participate
- • 2. ASA \> II patients
- • 3. Patients under 18 years of age
- • 4. Patients who are allergic to the drugs used
- • 5. Patients with mental illness
- • 6. Patients with alcohol or substance addiction
About Acibadem University
Acibadem University is a leading academic institution in Turkey, dedicated to advancing medical education, research, and healthcare innovation. With a focus on interdisciplinary collaboration, the university conducts cutting-edge clinical trials that aim to enhance patient outcomes and contribute to the global body of medical knowledge. Leveraging state-of-the-art facilities and a robust network of healthcare professionals, Acibadem University fosters an environment of excellence in clinical research, ensuring adherence to the highest ethical standards and regulatory compliance. Through its commitment to scientific discovery and education, the university plays a pivotal role in shaping the future of healthcare both nationally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Sevgi Bilgen
Study Chair
Acibadem University, Acibadem Kozyatagi Hastanesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials